Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
32.89
+0.02 (0.06%)
At close: Sep 11, 2026, 4:00 PM EDT
33.54
+0.65 (1.98%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.06 billion as of September 11, 2026. Its market cap has increased by 302.49% in one year.
Market Cap
2.06B
Enterprise Value
1.99B
1-Year Change
302.49%
Ranking
Category
Stock Price
$32.89
ChartMarket Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.06B, an increase of 476.84%. That is a compound annual growth rate of 24.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.06B | 19.06% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 2.20B |
| Palvella Therapeutics | 2.18B |
| Aurinia Pharmaceuticals | 2.16B |
| ADMA Biologics | 2.12B |
| Rapport Therapeutics | 2.11B |
| Zenas BioPharma | 2.10B |
| Mesoblast | 2.08B |
| Hemab Therapeutics Holdings | 2.08B |